Company Overview

Update
Founded:
2008
Headquarters:
Cambridge, MA
Funding:
$51.90M
Categories:
Biotechnology

Stemgent is a provider of reagents, services and training for scientists who study cellular reprogramming (iPS cells).

Description

Update

Stemgent works alongside some of the world's leading stem cell scientists in developing innovative technology and application solutions that provide researchers the tools to investigate and understand cellular reprogramming. Our mission is to help simplify and support stem cell research by producing products and services being designed by leading stem cell researchers. Specialties Cellular Reprogramming, iPS Cells, Media, Human iPSC Training & Services, mRNA Reprogramming, Stem Cell Research, Custom iPS cell lines, Pluriton, WIT, StainAlive, NutriStem

Current Team (3)

Update

Board Members and Advisors (4)

Update

Funding Rounds (8) - $51.90M

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    One Kendall Square, B6201

    Cambridge, MA 02139

    USA

Images (1)

Update
  • 39b1c99bf20fd31713bb85911b47b903